Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries

Author:

Marzo Roy Rillera,Ahmad AbsarORCID,Islam Md. SaifulORCID,Essar Mohammad Yasir,Heidler PetraORCID,King Isabel,Thiyagarajan ArulmaniORCID,Jermsittiparsert KittisakORCID,Songwathana Karnjana,Younus Delan AmeenORCID,El-Abasiri Radwa AbdullahORCID,Bicer Burcu KucukORCID,Pham Nhat TanORCID,Respati TitikORCID,Fitriyana SusanORCID,Faller Erwin MartinezORCID,Baldonado Aries MoralidadORCID,Billah Md Arif,Aung YadanarORCID,Hassan Shehu Muhammad,Asad Muhammad Mujtaba,El-Fass Kareem Ahmed,Bhattacharya Sudip,Shrestha Sunil,Hamza Nouran Ameen Elsayed,Friedmann Pascal,Head MichaelORCID,Lin YulanORCID,Yi Siyan

Abstract

Background Mass vaccination campaigns have significantly reduced the COVID-19 burden. However, vaccine hesitancy has posed significant global concerns. The purpose of this study was to determine the characteristics that influence perceptions of COVID-19 vaccine efficacy, acceptability, hesitancy and decision making to take vaccine among general adult populations in a variety of socioeconomic and cultural contexts. Methods Using a snowball sampling approach, we conducted an online cross-sectional study in 20 countries across four continents from February to May 2021. Results A total of 10,477 participants were included in the analyses with a mean age of 36±14.3 years. The findings revealed the prevalence of perceptions towards COVID-19 vaccine’s effectiveness (78.8%), acceptance (81.8%), hesitancy (47.2%), and drivers of vaccination decision-making (convenience [73.3%], health providers’ advice [81.8%], and costs [57.0%]). The county-wise distribution included effectiveness (67.8–95.9%; 67.8% in Egypt to 95.9% in Malaysia), acceptance (64.7–96.0%; 64.7% in Australia to 96.0% in Malaysia), hesitancy (31.5–86.0%; 31.5% in Egypt to 86.0% in Vietnam), convenience (49.7–95.7%; 49.7% in Austria to 95.7% in Malaysia), advice (66.1–97.3%; 66.1% in Austria to 97.3% in Malaysia), and costs (16.0–91.3%; 16.0% in Vietnam to 91.3% in Malaysia). In multivariable regression analysis, several socio-demographic characteristics were identified as associated factors of outcome variables including, i) vaccine effectiveness: younger age, male, urban residence, higher education, and higher income; ii) acceptance: younger age, male, urban residence, higher education, married, and higher income; and iii) hesitancy: male, higher education, employed, unmarried, and lower income. Likewise, the factors associated with vaccination decision-making including i) convenience: younger age, urban residence, higher education, married, and lower income; ii) advice: younger age, urban residence, higher education, unemployed/student, married, and medium income; and iii) costs: younger age, higher education, unemployed/student, and lower income. Conclusions Most participants believed that vaccination would effectively control and prevent COVID-19, and they would take vaccinations upon availability. Determinant factors found in this study are critical and should be considered as essential elements in developing COVID-19 vaccination campaigns to boost vaccination uptake in the populations.

Funder

Fujian Provincial Department of Science and Technology

Special Projects of the Central Government Guiding Local Science and Technology Development, China

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference60 articles.

1. Worldometers. Covid-19 Coronavirus Pandemic [cited 2021 September 6]. In: Worldometers [Internet]. Available from: https://www.worldometers.info/coronavirus/.

2. Health equity and COVID-19: global perspectives;E Shadmi;International Journal for Equity in Health,2020

3. The COVID-19 Pandemic: Effects on Low- and Middle-Income Countries;CL Bong;Anesth Analg,2020

4. Current burden on healthcare systems in low- and middle-income countries: recommendations for emergency care of COVID-19;H Hamid;Drugs Ther Perspect,2020

5. Nepal’s first case of COVID-19 and public health response;R Shrestha;J Travel Med,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3